OL
Optas LLC Portfolio holdings
AUM
$526M
This Quarter Return
+14.4%
1 Year Return
+20.94%
3 Year Return
+88.04%
5 Year Return
+118.99%
10 Year Return
–
AUM
$526M
AUM Growth
+$526M
(-8.4%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-21.26%
Top 10 Holdings %
Top 10 Hldgs %
44.31%
Holding
402
New
90
Increased
131
Reduced
123
Closed
42
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$9.28M |
| 2 |
eBay
EBAY
|
$2.52M |
| 3 |
Walt Disney
DIS
|
$1.2M |
| 4 |
Microsoft
MSFT
|
$1.08M |
| 5 |
Broadcom
AVGO
|
$732K |
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
$58.7M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$21.9M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
$21.2M |
| 4 |
Vanguard Russell 1000 Value ETF
VONV
|
$10.5M |
| 5 |
Vanguard Mid-Cap ETF
VO
|
$8.82M |
Sector Composition
| 1 | Technology | 19.79% |
| 2 | Communication Services | 12.7% |
| 3 | Financials | 6.83% |
| 4 | Consumer Discretionary | 5.64% |
| 5 | Industrials | 4.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Vanguard Consumer Staples ETF
VDC
$7.6B
| $455K | 0.09% |
2,078
-1,793
| -46% | -$393K |
|
152
Essex Property Trust
ESS
$16.8B
| $454K | 0.09% |
+1,602
| New | +$454K |
|
153
Unilever
UL
$156B
| $453K | 0.09% |
7,407
+1,387
| +23% | +$84.8K |
|
154
Amgen
AMGN
$154B
| $448K | 0.09% |
1,604
+243
| +18% | +$67.8K |
|
155
Constellation Energy
CEG
$96B
| $443K | 0.08% |
1,371
-153
| -10% | -$49.4K |
|
156
Palo Alto Networks
PANW
$127B
| $442K | 0.08% |
2,162
+45
| +2% | +$9.21K |
|
157
Fox Class A
FOXA
$27.2B
| $440K | 0.08% |
7,851
+456
| +6% | +$25.6K |
|
158
Zillow
Z
$19.8B
| $439K | 0.08% |
6,268
-5,937
| -49% | -$416K |
|
159
Marsh & McLennan
MMC
$101B
| $437K | 0.08% |
1,998
-28
| -1% | -$6.12K |
|
160
Tenet Healthcare
THC
$16.4B
| $435K | 0.08% |
2,472
-21
| -0.8% | -$3.7K |
|
161
Toyota
TM
$252B
| $434K | 0.08% |
2,521
-212
| -8% | -$36.5K |
|
162
CVS Health
CVS
$94B
| $433K | 0.08% |
+6,284
| New | +$433K |
|
163
Banco Bilbao Vizcaya Argentaria
BBVA
$104B
| $427K | 0.08% |
27,749
+323
| +1% | +$4.97K |
|
164
DocuSign
DOCU
$15B
| $412K | 0.08% |
5,294
+2,206
| +71% | +$172K |
|
165
Novartis
NVS
$245B
| $409K | 0.08% |
3,379
-95
| -3% | -$11.5K |
|
166
PepsiCo
PEP
$206B
| $407K | 0.08% |
3,082
-947
| -24% | -$125K |
|
167
Analog Devices
ADI
$122B
| $405K | 0.08% |
1,703
+345
| +25% | +$82.1K |
|
168
Vertex Pharmaceuticals
VRTX
$103B
| $404K | 0.08% |
907
-875
| -49% | -$390K |
|
169
DuPont de Nemours
DD
$31.7B
| $402K | 0.08% |
+5,865
| New | +$402K |
|
170
Boston Scientific
BSX
$158B
| $402K | 0.08% |
3,741
-186
| -5% | -$20K |
|
171
L3Harris
LHX
$51.5B
| $401K | 0.08% |
1,599
-38
| -2% | -$9.53K |
|
172
PPG Industries
PPG
$24.7B
| $392K | 0.07% |
+3,450
| New | +$392K |
|
173
Intuitive Surgical
ISRG
$168B
| $391K | 0.07% |
719
-2
| -0.3% | -$1.09K |
|
174
Broadridge
BR
$29.5B
| $391K | 0.07% |
1,607
-44
| -3% | -$10.7K |
|
175
Citigroup
C
$174B
| $382K | 0.07% |
4,491
-40
| -0.9% | -$3.41K |
|